Dual expression of matrix metalloproteinase-2 and membrane-type 1- matrix metalloproteinase in fibrotic human livers

Hepatology

Volumn 26, Issue 6, 1997, Pages 1521-1529

  Takahara, Terumi ^a   Furui, Kei ^a   Yata, Yutaka ^a   Jin, Bo ^a   Zhang, Li Ping ^a   Nambu, Shuji ^a   Sato, Hiroshi ^b   Seiki, Motoharu ^b   Watanabe, Akiharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENZYME LOCALIZATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030724689     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260620     Document Type: Article

References (15)

1. Arthur MJP. Matrix degradation in the liver. Semin Liver Dis 1990;10: 47-55.
2. Arthur MJP. Matrix degradation in the liver. In: Surrenti C, Casini A, Milani S, Pinzani M, eds. Fat-Storing Cells and Liver Fibrosis. Lancaster: Kluwer Academic Publishers, 1994:110-127.
3. Brannstrom M, Woessner JF, Koos RD, Sear CH, LeMaire WJ. Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary. Endocrinology 1988;122:1715-1721.
4. Brenner CA, Adler RR, Rappolee DA, Pedersen RA, Werb Z. Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev 1989;3:848-859.
5. Kinoh H, Sato H, Tsunezuka Y, Takino T, Kawashima A, Okada Y, Seiki M. MT-MMP, the cell activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 1996;109:953-959.
6. Liotta LA, Abe S, Gehron-Robey P, Martin GR. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci U S A 1979;76:2268-2272.
7. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64:327-336.
8. Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993;24:209-218.
9. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, et al. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. HEPATOLOGY 1995;21:787-795.
10. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-125.
11. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
12. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 1992;267: 21712-21719.
13. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki A. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994;370:61-65.
14. Will H, Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995;231:602-608.
15. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 1995;270:23013-23020.